Advent Pharma Income Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	516.48	500.49	571.67	558.05	530.47	503.6
Revenue Growth (YoY)	2.10%	-12.45%	2.44%	5.20%	5.34%	-5.70%
Cost of Revenue	355.28	324.86	343.77	335.14	310.31	288
Gross Profit	161.2	175.63	227.9	222.91	220.16	215.61
Selling, General & Admin	78.2	80.04	86.26	87.55	86.78	79.18
Operating Expenses	78.2	80.04	86.26	87.55	86.78	79.18
Operating Income	83	95.58	141.65	135.36	133.38	136.42
Interest Expense	-9.01	-9.16	-8.09	-6.63	-4.11	-4.9
Interest & Investment Income	0.02	0.02	0.02	0.01	1.1	2.93
Other Non Operating Income (Expenses)	-0.16	-0.16	-0.18	-0.11	-0.08	0.12
EBT Excluding Unusual Items	73.85	86.29	133.39	128.63	130.3	134.58
Gain (Loss) on Sale of Assets	-	-	-29.61	-	-	-0.39
Pretax Income	73.85	86.29	103.78	128.63	130.3	134.19
Income Tax Expense	16.62	19.41	19.79	29.99	32.76	20.6
Net Income	57.23	66.87	83.99	98.64	97.53	113.59
Net Income to Common	57.23	66.87	83.99	98.64	97.53	113.59
Net Income Growth	-2.09%	-20.38%	-14.85%	1.14%	-14.14%	-2.96%
Shares Outstanding (Basic)	93	93	93	93	93	93
Shares Outstanding (Diluted)	93	93	93	93	93	93
Shares Change (YoY)	-0.63%	-	-	-	-	-
EPS (Basic)	0.62	0.72	0.90	1.06	1.05	1.22
EPS (Diluted)	0.62	0.72	0.90	1.06	1.05	1.22
EPS Growth	-1.47%	-20.38%	-14.85%	1.14%	-14.14%	-2.96%
Free Cash Flow	8.73	20.56	13.08	2.56	-11.56	-3.67
Free Cash Flow Per Share	0.09	0.22	0.14	0.03	-0.12	-0.04
Dividend Per Share	-	0.050	0.100	0.200	0.200	0.196
Dividend Growth	-	-50.00%	-50.00%	-	1.99%	-
Gross Margin	31.21%	35.09%	39.87%	39.95%	41.50%	42.81%
Operating Margin	16.07%	19.10%	24.78%	24.26%	25.14%	27.09%
Profit Margin	11.08%	13.36%	14.69%	17.68%	18.39%	22.56%
Free Cash Flow Margin	1.69%	4.11%	2.29%	0.46%	-2.18%	-0.73%
EBITDA	144.34	158.05	207.57	193.96	175.07	174.59
EBITDA Margin	27.95%	31.58%	36.31%	34.76%	33.00%	34.67%
D&A For EBITDA	61.34	62.47	65.93	58.6	41.69	38.17
EBIT	83	95.58	141.65	135.36	133.38	136.42
EBIT Margin	16.07%	19.10%	24.78%	24.26%	25.14%	27.09%
Effective Tax Rate	22.50%	22.50%	19.07%	23.31%	25.15%	15.35%
Advertising Expenses	-	0.12	0.15	0.19	0.18	0.15

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.